Clinical Trials Browser

Phase EARLY_PHASE1 × Sarcoma, Kaposi × Nivolumab × Clear all

NCT03316274 2024-06-25

Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma

Phase EARLY_PHASE1 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi